XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Based Compensation - Schedule of Stock Options and SARs Transactions (Details) - Stock Options/SARs - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Number of Stock Options/SARs    
Beginning balance (in shares) 4,225 9,969
Granted (in shares) 0 2
Exercised (in shares) (300) (3,928)
Forfeited (in shares) (57) (137)
Ending balance (in shares) 3,868 5,906
Vested or Expected to Vest (in shares) 3,727 5,603
Exercisable (in shares) 2,178 2,305
Weighted Average Exercise Price    
Beginning balance (in USD per share) $ 77.49 $ 84.37
Granted (in USD per share) 0 97.64
Exercised (in USD per share) 77.26 93.12
Forfeited (in USD per share) 87.49 87.54
Ending balance (in USD per share) 77.37 78.49
Vested or Expected to Vest (in USD per share) 77.74 79.15
Exercisable (in USD per share) $ 84.87 $ 97.46
Additional Disclosures    
Intrinsic value of stock options/SARs exercised $ 13 $ 108
Intrinsic value of stock options/SARs outstanding $ 150 $ 202
Weighted average remaining contractual life for stock options/SARs outstanding (in years) 3 years 8 months 12 days 4 years 6 months
Intrinsic value of stock options/SARs vested or expected to vest $ 143 $ 189
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) 3 years 7 months 6 days 4 years 4 months 24 days
Aggregate intrinsic value for exercisable units $ 71 $ 44
Weighted average remaining contractual life for exercisable options/SARs (in years) 2 years 8 months 12 days 2 years 8 months 12 days